Latest Breaking News On - Maia hansen - Page 1 : comparemela.com

Athersys end 2023 on a down note | Crain s Cleveland Business

Athersys end 2023 on a down note | Crain s Cleveland Business
crainscleveland.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from crainscleveland.com Daily Mail and Mail on Sunday newspapers.

Maia hansenDaniela camardoAthersys incExchange commission

Athersys ends 2023 on a down note | Crain s Cleveland Business

Athersys ends 2023 on a down note | Crain s Cleveland Business
crainscleveland.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from crainscleveland.com Daily Mail and Mail on Sunday newspapers.

Maia hansenDaniela camardoExchange commissionAthersys inc

Athersys to Host Business Update Conference Call on August 9th

Athersys, Inc. , a cell therapy and regenerative medicine company developing MultiStem® for critical care indications, announced today it will host a business update conference call on August 9,.

Maia hansenWillie maysKasey rosadoDan camardoAthersys incChief executive officerChief operating officerInterim chief financial officerExecutive vice presidentRegenerative medicineEastern timePrivate securities litigation reform act

Athersys to Host Business Update Conference Call on April 20th

Athersys, Inc. , a cell therapy and regenerative medicine company developing MultiStem® for critical care indications, announced today it will host a business update conference call on April 20,. | April 10, 2023

Kasey rosadoMaia hansenWillie maysDan camardoAthersys incChief executive officerChief operating officerInterim chief financial officerExecutive vice presidentRegenerative medicineEastern timePrivate securities litigation reform actNc stock exchangePress releasePril athx us04744l2051

Athersys to Host Business Update Conference Call on April 20th

CLEVELAND (BUSINESS WIRE) Athersys, Inc. (NASDAQ: ATHX), a cell therapy and regenerative medicine company developing MultiStem® (invimestrocel) for critical care indications, announced today it will host a business update conference call on April 20, 2023 at 11:00 a.m. Eastern Time. Dan Camardo, Chief Executive Of.

Ellen gurleyDan camardoMaia hansenWillie maysKasey rosadoAthersys incCorporate communicationsChief executive officerChief operating officerInterim chief financial officerExecutive vice presidentRegenerative medicineEastern timePrivate securities litigation reform act